Assessing safety, efficacy and transmission blocking properties of the new anti-malarial KAF156 combined with a new formulation of lumefantrine in children and adults with uncomplicated Plasmodium sp. malaria in West and Central Africa (WANECAM II) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Abdoulaye Djimde | Gabon, Burkina Faso, Mali, Niger
Optimization of Seasonal Malaria Chemoprevention (SMC) delivery and its effects on the acquisition of malaria immunity National Institute of Allergy and Infectious Diseases (NIAID), NIH, University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Alassane Dicko | Mali
Evaluation of Seasonal Malaria Chemoprevention (SMC) pilot in Kita District, Mali U.S. President’s Malaria Initiative (PMI), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Seydou Doumbia, Alassane Dicko | Mali
Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria Vaccine African Malaria Network Trust (AMANET), Tanzania, University of Bamako, Mali | Mahamadou S. Sissoko | Africa, Western, Mali
Assessing safety, efficacy and transmission blocking properties of the new anti-malarial KAF156 combined with a new formulation of lumefantrine in children and adults with uncomplicated Plasmodium sp. malaria in West and Central Africa (WANECAM II) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Abdoulaye…
EDCTP-Clinical Research and Product Development Fellow: Dr Amadou Hamidou Togo, MD, PhD, Université des Sciences Techniques et Technologiques de Bamako(USTTB), Faculty of Pharmacy (FAPH), Malaria Research and Training Center (MRTC) Grant Agreement number: TMA2019IF-2867 Grant Title: TMA2019 IF [ TOGO] Call for proposals: TMA2019 IF [ TOGO] The purpose of this Call for Proposals is to support researchers and members…
WANECAM is the West African Network for Clinical Trials of Antimalarial drugs. This network is being supported by grants from the European & Developing Countries Clinical Trials Partnership (EDCTP). The WANECAM 2 project aims to accelerate the development of the Ganaplacide/lumefantrine combination for the treatment of uncomplicated malaria by conducting clinical trials in four countries…